163 related articles for article (PubMed ID: 35474106)
1. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease.
Tangvoraphonkchai K; Suttichaimongkol T; Kularbkaew C; Sangaimwibool P; Sukeepaisarnjaroen W
Sci Rep; 2022 Apr; 12(1):6757. PubMed ID: 35474106
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
[TBL] [Abstract][Full Text] [Related]
3. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
[TBL] [Abstract][Full Text] [Related]
8. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
10. Serum Mac-2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graft.
Sasaki R; Miyaaki H; Narita S; Fukushima M; Haraguchi M; Miuma S; Hidaka M; Eguchi S; Okudaira S; Abe K; Nakao K
Clin Transplant; 2021 Feb; 35(2):e14175. PubMed ID: 33247961
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
12. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation.
Kimura Y; Taura K; Hai Nam N; Uemoto Y; Yoshino K; Ikeno Y; Okuda Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Anazawa T; Fukumitsu K; Ito T; Yagi S; Kamo N; Seo S; Iwaisako K; Hata K; Imai T; Uemoto S
Liver Transpl; 2021 Feb; 27(3):403-415. PubMed ID: 32780942
[TBL] [Abstract][Full Text] [Related]
13. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
[TBL] [Abstract][Full Text] [Related]
15. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
[TBL] [Abstract][Full Text] [Related]
16. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.
Pham TTT; Ho DT; Nguyen T
World J Hepatol; 2020 May; 12(5):220-229. PubMed ID: 32547689
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
Hur M; Park M; Moon HW; Choe WH; Lee CH
Ann Lab Med; 2022 Mar; 42(2):249-257. PubMed ID: 34635616
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
[TBL] [Abstract][Full Text] [Related]
20. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
